Industrial Policy & Trade Monitor· 2675 actions· ✨ 91 recent

The US Department of Commerce preliminarily determined that producers and exporters of silicon metal from Kazakhstan received countervailable subsidies at a 120.00% economy-wide rate, and instructed US Customs and Border Protection to begin collecting cash deposits from importers at that rate. The countervailing-duty investigation was initiated 2020-07-27 following a June 2020 petition by Globe Specialty Metals, Inc. and Mississippi Silicon LLC, the same domestic petitioners behind the concurrent antidumping cases against Bosnia and Herzegovina, Iceland, and Malaysia. 2019 Kazakh silicon metal imports subject to the case were valued at approximately $14.9 million.

The US Department of Commerce preliminarily determined that silicon metal from Bosnia and Herzegovina and Iceland is being sold in the United States at less than fair value, and instructed US Customs and Border Protection to begin collecting cash deposits from importers. Bosnia and Herzegovina's sole respondent, R-S Silicon d.o.o., and the all-others rate were set at 21.41%; Iceland's sole respondent, PCC Bakki Silicon hf, received 47.54%, with the all-others rate at 37.83%. A concurrent antidumping investigation of silicon metal from Malaysia, initiated on the same 2020-07-27 date, was not part of this preliminary determination and remained pending. The case followed a July 2020 petition by Globe Specialty Metals, Inc. and Mississippi Silicon LLC.

The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) on 21 July 2020 via Gazette Notification, with an outlay of Rs 6,940 crore (~USD 920m) over FY 2020-21 to FY 2027-28. The scheme covers 41 identified critical bulk-drug products across four target segments — fermentation-based (Key Fermentation; Niche Fermentation) and chemical synthesis-based (Key Chemical Synthesis; Niche Chemical Synthesis) — paying 20% incentive on incremental sales for fermentation-based products (years 1-4) tapering to 15% (year 5) and 5% (year 6), and a flat 20% over 5 years for chemically-synthesised products. The stated objective is to reduce India's ~70% bulk-drug import dependence on China by establishing greenfield domestic manufacturing capacity with at least 90% domestic value addition for fermentation products and 70% for chemical-synthesis products.